- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02951572
Non-invasive Ventilation and Physical Activity
Non-invasive Ventilation and Physical Activity in Patients With Neuromuscular Disorders and Thoracic Wall Disorders
Study Overview
Detailed Description
Patients with neuromuscular disorders and thoracic deformations develop alveolar hypoventilation during their disease progression. At that time, non-invasive ventilation(NIV) can be started as treatment.
Fatigue and daytime sleepiness are typical symptoms of alveolar hypoventilation. NIV has the intention to improve these symptoms but no research has been performed whether these improvements also objectively improve physical activity. Further on, no research has been performed on muscle strength and muscle fatigue.
Patients' physical activity, physical capacity and sleep quality will be measured before NIV initiation, after 3 months and 1 year of NIV use.
To start NIV, patients will be admitted to our sleep laboratory for 5 days/4 nights. Polysomnography will be used during NIV titration.
Physical activity will each time be measured by 2 activity monitors during 5 days.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium, 3000
- UZ Leuven
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- restrictive pulmonary function test AND
- symptoms of nocturnal alveolar hypoventilation or
- increased daytime pressure of arterial CO2 (PaCO2) (>45 mmHg) or
- >= 10 mmHg increase in PaCO2 during sleep in comparison to a normal awake supine value
Exclusion Criteria:
- patients < 16 years
- severe cardiac arrythmias or conduction disturbances
- severe mental disturbances
- amyotrophic lateral sclerosis
- total wheelchair-dependent patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Patients with RLD initiating NIV
Patients with RLD initiating NIV according to Belgian Health guidelines are followed-up before and after NIV initiation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average daily walking time
Time Frame: Measured before initiation of NIV
|
Average daily walking time will be measured by the McRoberts physical activity monitor
|
Measured before initiation of NIV
|
Average daily walking time
Time Frame: Measured after 3 months of NIV
|
Average daily walking time will be measured by the McRoberts physical activity monitor
|
Measured after 3 months of NIV
|
Average daily walking time
Time Frame: Measured after 1 year of NIV
|
Average daily walking time will be measured by the McRoberts physical activity monitor
|
Measured after 1 year of NIV
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in functional exercise capacity
Time Frame: Before NIV initiation
|
Six minute walking test
|
Before NIV initiation
|
Change in muscle strength
Time Frame: Before NIV initiation
|
Quadriceps muscle strength will be measured by magnetic stimulation.
MicroFet measurements of wrist flexion/extension and ankle dorsiflexion/plantar flexion Respiratory muscle strength will be measured by maximal inspiratory pressure and sniff nasal inspiratory pressure
|
Before NIV initiation
|
Change in quadriceps fatiguability
Time Frame: Before NIV intiation
|
Use of magnetic stimulation before and after performing fatigue test of the quadriceps muscle
|
Before NIV intiation
|
Change in sleep structure and quality of sleep
Time Frame: Before NIV intiation
|
Full polysomnography will be used to get insight in sleep improvement
|
Before NIV intiation
|
Change in functional exercise capacity
Time Frame: After 3 months of NIV use
|
Six minute walking test
|
After 3 months of NIV use
|
Change in functional exercise capacity
Time Frame: After 1 year NIV use
|
Six minute walking test
|
After 1 year NIV use
|
Change in muscle strength
Time Frame: After 3 months of NIV use
|
Quadriceps muscle strength will be measured by magnetic stimulation.
MicroFet measurements of wrist flexion/extension and ankle dorsiflexion/plantar flexion Respiratory muscle strength will be measured by maximal inspiratory pressure and sniff nasal inspiratory pressure
|
After 3 months of NIV use
|
Change in muscle strength
Time Frame: After 1 year NIV use
|
Quadriceps muscle strength will be measured by magnetic stimulation.
MicroFet measurements of wrist flexion/extension and ankle dorsiflexion/plantar flexion Respiratory muscle strength will be measured by maximal inspiratory pressure and sniff nasal inspiratory pressure
|
After 1 year NIV use
|
Change in quadriceps fatiguability
Time Frame: After 3 months of NIV use
|
Use of magnetic stimulation before and after performing fatigue test of the quadriceps muscle
|
After 3 months of NIV use
|
Change in quadriceps fatiguability
Time Frame: After 1 year NIV use
|
Use of magnetic stimulation before and after performing fatigue test of the quadriceps muscle
|
After 1 year NIV use
|
Change in sleep structure and quality of sleep
Time Frame: After 3 months of NIV use
|
Full polysomnography will be used to get insight in sleep improvement
|
After 3 months of NIV use
|
Change in sleep structure and quality of sleep
Time Frame: After 1 year NIV use
|
Full polysomnography will be used to get insight in sleep improvement
|
After 1 year NIV use
|
Collaborators and Investigators
Investigators
- Principal Investigator: Dries Testelmans, MD, PhD, Universitaire Ziekenhuizen KU Leuven
- Study Director: Bertien Buyse, MD,PhD, Universitaire Ziekenhuizen KU Leuven
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S54220
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neuromuscular Diseases
-
Brugmann University HospitalCompletedAnesthesia, General | Neuromuscular Transmission DisordersBelgium
-
University Hospital, ToursCompletedNeuromuscular Diseases in Children | Neuromuscular Diseases in InfantsFrance
-
Ottawa Hospital Research InstituteRecruiting
-
University of FloridaTerminated
-
Penwest Pharmaceuticals Co.TerminatedNeuromuscular DiseaseUnited Kingdom
-
Centre d'Investigation Clinique et Technologique...Association Française contre les Myopathies (AFM), ParisCompletedCommunication | Neuromuscular DiseaseFrance
-
Linde AGCompletedFunctional Test, COPD, Neuromuscular Disorders, Mechanical Ventilation, Weaning, DisabilityArgentina, Colombia, Germany
-
National Institute of Nursing Research (NINR)TerminatedNeuromuscular DiseaseUnited States
-
Landon Pediatric FoundationCompleted
Clinical Trials on NIV
-
Rennes University HospitalRecruitingChronic Obstructive Pulmonary Disease (COPD) | Obesity With a BMI Greater Than 30 | Acute Respiratory Distress in Adult Intensive CareFrance
-
University Hospital, RouenUnknown
-
Vejle HospitalCompletedRespiratory Insufficiency | Acute Respiratory InsufficiencyDenmark
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Politecnico di MilanoCompletedPrematurity | Neonatal Respiratory Distress SyndromeItaly
-
Taipei Veterans General Hospital, TaiwanCompleted
-
Inspir Labs Ltd.Recruiting
-
Spaulding Rehabilitation HospitalCompletedSpinal Cord InjuryUnited States
-
South Valley UniversityCompletedAcute Respiratory Failure Post Surgical (Diagnosis)Egypt
-
Sultan Qaboos UniversityTerminatedAcute Respiratory Distress Syndrome Caused by COVID-19Oman
-
University of Nove de JulhoUnknown